SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics $CAPR is trending due to anticipation surrounding the release of pivotal Phase 3 HOPE-3 study data for Duchenne Muscular Dystrophy. The community is buzzing with speculation about the results and potential for a short squeeze, while also debating the validity of past criticism from prominent short sellers. Some traders are setting very high price targets based on the potential for FDA approval and buyout prospects.

$SMOL is the first memecoin with a verified OnlyFans launched on Solana via pump.fun. It follows Smol, a rescued Alabama dachshund who survived hoarding, shelter hunger, and a 5-day post-spay escape before finding her forever home. Now pampered with treats and spa days, she shares wholesome content—no adult themes, just derpy faces, snack videos, and rescue love. $SMOL aims to normalize kindness and support animal welfare through the creator economy.

Smol Fans

$SMOL is trending as a Solana-based meme token with a unique narrative centered around a rescue dog using an OnlyFans account to fund its crypto venture, capturing community interest. Social media virality is a key discussion point, with many drawing parallels to the $GME movement and suggesting $SMOL could become a leading celebrity-driven cryptocurrency. Community members highlight the project's organic growth, strong narrative, and potential to disrupt the OnlyFans landscape.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending following a positive upgrade driven by anticipated data-center growth and its acquisition of Celestial AI, which is viewed as a strategic move into AI interconnectivity. The community is weighing whether to chase the breakout or await a potential pullback, while analysts are raising price targets. Upgrades and catalysts are aligning after earnings, with many feeling it's a good entry point.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is trending as the community discusses its potential following a recent partnership, speculating on future revenue growth and potential acquisitions. Despite some short-term price fluctuations, investors are focused on the company's long-term prospects in the growing robotics and autonomous delivery sector, with some eyeing specific price targets. Chatter also revolves around potential government investment and expansion into new cities.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CRWD is trending following analyst upgrades and price target increases after a strong quarter, with focus on ARR re-acceleration and successful scaling of its Flex licensing model. Community members are actively discussing the stock's steady buyer resilience and potential longer cycle strength, while also acknowledging the high expectations and potential for volatility. The cybersecurity sector's strength is also contributing to the positive sentiment.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

Clene Inc. ($CLNN) is trending due to positive ALS biomarker data for their drug candidate CNM-Au8, reigniting community excitement around a potential accelerated approval filing with the FDA. Discussions revolve around whether the data package meets the FDA's criteria, with many highlighting statistically significant NfL reductions and biomarker concordance. Community members are closely watching for further company announcements and potential implications for ALS patients.

American Eagle Outfitters, Inc. is a multi-brand specialty retailer, which offers an assortment of apparel and accessories for men and women under the American Eagle Outfitters brand, and intimates, apparel and personal care products for women under the Aerie brand. The firm operates stores in the United States, Canada, Mexico, Hong Kong, China and the United Kingdom. It also acquired two emerging brands to complement its existing brands, Tailgate, a vintage sports-inspired apparel brand, and Todd Snyder New York, a premium menswear brand. The company was founded in 1977 and is headquartered in Pittsburgh, PA.

American Eagle Outfitters Inc.

American Eagle Outfitters, Inc.

American Eagle Outfitters is trending after reporting strong earnings and raising its full-year sales forecast, with much discussion around the impact of celebrity marketing campaigns, especially those featuring Sidney Sweeney. The community is closely watching the stock's potential for further gains, with some anticipating a possible short squeeze. Broader retail sector trends and overall market sentiment are also influencing the conversation around AEO.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings is trending due to a major government contract win for an autonomous border-protection drone system, sparking significant community excitement. Investors are actively discussing the potential impact of this contract on future growth, the company's position in the defense sector, and possible short squeezes. The contract news has reinforced optimism about Ondas's long-term prospects.

Macy's, Inc. engages in the retail of apparel, accessories, cosmetics, home furnishings, and other consumer goods. The firm's brands include Macy's, Bloomingdale's, and Bluemercury. It offers men's, women's, and children's apparel, women's accessories, intimate apparel, shoes, cosmetics, fragrances, as well as home and miscellaneous products. The company was founded by Rowland H. Macy in 1858 and is headquartered in New York, NY.

Macy`s Inc

Macy's Inc

Macy's stock is trending despite pre-market losses, driven by a better-than-expected earnings report that included raised full-year guidance. Community discussions revolve around the seemingly contradictory price drop given the positive earnings, with some speculating about holiday outlook concerns and others seeing a buying opportunity. The cautious holiday spending outlook from the CEO tempers positive sentiment around the company's turnaround progress.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is trending despite a recent earnings beat and raised guidance, fueled by concerns around slowing growth and AI agent contributions; Piper Sandler slashed its price target, contributing to negative sentiment. While BTIG maintains a Buy rating, the community is actively debating whether the stock will recover, with some expressing frustration and others anticipating a reversal. Discussions also involve the company's valuation and potential for a short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Virtus Advisers LLC

Virtus Advisers LLC cut its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 74.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The...

Loomis Sayles & Co. L P Acquires New Position in Neurocrine Biosciences, Inc. $NBIX

Loomis Sayles & Co. L P bought a new position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with...

Distillate Capital Partners LLC Sells 8,175 Shares of Neurocrine Biosciences, Inc. $NBIX

Distillate Capital Partners LLC lessened its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 6.3% in the second quarter, according to the company in its most recent filing...

Edgestream Partners L.P. Takes $9.25 Million Position in Neurocrine Biosciences, Inc. $NBIX

Edgestream Partners L.P. purchased a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The...

Skandinaviska Enskilda Banken AB publ Reduces Holdings in Neurocrine Biosciences, Inc. $NBIX

Skandinaviska Enskilda Banken AB publ reduced its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 49.3% during the second quarter, according to the company in its...

Quadrature Capital Ltd Purchases 11,162 Shares of Neurocrine Biosciences, Inc. $NBIX

Quadrature Capital Ltd increased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 306.1% in the second quarter, according to the company in its most recent filing with the...

Capital Fund Management S.A. Grows Holdings in Neurocrine Biosciences, Inc. $NBIX

Capital Fund Management S.A. lifted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 15.9% during the 2nd quarter, according to the company in its most recent 13F...

Prudential Financial Inc. Purchases 26,030 Shares of Neurocrine Biosciences, Inc. $NBIX

Prudential Financial Inc. increased its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 21.8% during the 2nd quarter, according to its most recent filing with the...

Creative Planning Raises Position in Neurocrine Biosciences, Inc. $NBIX

Creative Planning lifted its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 31.6% during the 2nd quarter, according to the company in its most recent 13F filing with...

Insider Selling: Neurocrine Biosciences (NASDAQ:NBIX) Director Sells 15,000 Shares of Stock

Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Get Free Report) Director George Morrow sold 15,000 shares of the business's stock in a transaction that occurred on Tuesday, November 25th. The stock was...

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Current Price	$152.48
Prev Close	$150.88
Open	$151.13
Dividend Yield	0.00%
50-Day Moving Average	$142.98
Beta	0.69
Avg. Volume	1.1M
PE Ratio	36.41

52-Week High	$157.67
52-Week Low	$84.23
Market Capitalization	$15.2B
EPS (Annual)	$3.29
Price to Book	5.06
Revenue Per Employee	$1.31M
Enterprise Value/EBITDA	N/A

NBIX
Neurocrine Biosciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NBIX News

NBIXNeurocrine Biosciences, Inc.